Human TMED4/ERS25/GMP25iso ORF/cDNA clone-Lentivirus particle (NM_182547)
Cat. No.: vGMLP002599
Pre-made Human TMED4/ERS25/GMP25iso Lentiviral expression plasmid for TMED4 lentivirus packaging, TMED4 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
The GM Vector Core (GMVC) specializes in custom lentivirus development and offers a range of lentivirus manufacturing solutions, leveraging state-of-the-art processes. Learn more about our services.
Go to
TMED4/ERS25 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Catalog No. | Product Name | lentivirus Grade | lentivirus quantity |
---|---|---|---|
vGMLP002599 | Human TMED4 Lentivirus particle | Pilot Grade | 1.0E+8TU |
5.0E+8TU | |||
1.0E+9TU | |||
Research Grade | 1.0E+8TU | ||
5.0E+8TU | |||
1.0E+9TU | |||
GMP-like Grade | inquiry | ||
GMP Grade | inquiry |
Product Description
Catalog ID | vGMLP002599 |
Gene Name | TMED4 |
Accession Number | NM_182547 |
Gene ID | 222068 |
Species | Human |
Product Type | Lentivirus particle (overexpression) |
Insert Length | 684 bp |
Gene Alias | ERS25,GMP25iso,HNLF,p24a3,p24alpha3 |
Fluorescent Reporter | ZsGreen |
Mammalian Cell Selection | Puromyocin |
Fusion Tag | 3xflag (C-Terminal) |
Promoter | CMV |
Resistance | Amplicin |
ORF Nucleotide Sequence | ATGGCAGGTGTCGGGGCTGGGCCTCTGCGGGCGATGGGGCGGCAGGCCCTGCTGCTTCTCGCGCTGTGCGCCACAGGCGCCCAGGGGCTCTACTTCCACATCGGCGAGACCGAGAAGCGCTGTTTCATCGAGGAAATCCCCGACGAGACCATGGTCATCGGCAACTATCGTACCCAGATGTGGGATAAGCAGAAGGAGGTCTTCCTGCCCTCGACCCCTGGCCTGGGCATGCACGTGGAAGTGAAGGACCCCGACGGCAAGGTGGTGCTGTCCCGGCAGTACGGCTCGGAGGGCCGCTTCACGTTCACCTCCCACACGCCCGGTGACCATCAAATCTGTCTGCACTCCAATTCTACCAGGATGGCTCTCTTCGCTGGTGGCAAACTGCGGGTGCATCTCGACATCCAGGTTGGGGAGCATGCCAACAACTACCCTGAGATTGCTGCAAAAGATAAGCTGACGGAGCTACAGCTCCGCGCCCGCCAGTTGCTTGATCAGGTGGAACAGATTCAGAAGGAGCAGGATTACCAAAGGTATCGTGAAGAGCGCTTCCGACTGACGAGCGAGAGCACCAACCAGAGGGTCCTATGGTGGTCCATTGCTCAGACTGTCATCCTCATCCTCACTGGCATCTGGCAGATGCGTCACCTCAAGAGCTTCTTTGAGGCCAAGAAGCTGGTGTAG |
ORF Protein Sequence | MAGVGAGPLRAMGRQALLLLALCATGAQGLYFHIGETEKRCFIEEIPDETMVIGNYRTQMWDKQKEVFLPSTPGLGMHVEVKDPDGKVVLSRQYGSEGRFTFTSHTPGDHQICLHSNSTRMALFAGGKLRVHLDIQVGEHANNYPEIAAKDKLTELQLRARQLLDQVEQIQKEQDYQRYREERFRLTSESTNQRVLWWSIAQTVILILTGIWQMRHLKSFFEAKKLV |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
---|---|---|
Target Antibody | GM-Tg-g-SE0509-Ab | Anti-TMED4/ ERS25/ GMP25iso functional antibody |
Target Antigen | GM-Tg-g-SE0509-Ag | TMED4 protein |
ORF Viral Vector | pGMLP002599 | Human TMED4 Lentivirus plasmid |
ORF Viral Vector | vGMLP002599 | Human TMED4 Lentivirus particle |
Target information
Target ID | GM-SE0509 |
Target Name | TMED4 |
Gene Group Identifier (Target Gene ID in Homo species) |
222068 |
Gene ID |
100065195 (Equus caballus), 101095809 (Felis catus), 103694 (Mus musculus), 222068 (Homo sapiens) 305502 (Rattus norvegicus), 475498 (Canis lupus familiaris), 508729 (Bos taurus), 699105 (Macaca mulatta) |
Gene Symbols & Synonyms | TMED4,Tmed4,1110014L17Rik,HNLF,ERS25,p24a3,GMP25iso,p24alpha3,RGD1306319 |
Target Alternative Names | TMED4,Transmembrane emp24 domain-containing protein 4,Endoplasmic reticulum stress-response protein 25 (ERS25), GMP25iso, Putative NF-kappa-B-activating protein 156, p24 family protein alpha-3 (p24alpha3),HNLF,ERS25,p24a3,GMP25iso,p24alpha3 |
Uniprot Accession |
Q7Z7H5,Q8R1V4
Additional SwissProt Accessions: Q8R1V4,Q7Z7H5 |
Uniprot Entry Name | |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | |
Disease from KEGG | |
Gene Ensembl | ENSMUSG00000004394, ENSG00000158604, ENSCAFG00845012302, ENSBTAG00000010612, ENSMMUG00000002650 |
Target Classification |
About GMVC
GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.